Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis

Célia Gotorbe1, Fabien Segui1, William Echavidre1

  • 1Biomedical Department, Centre Scientifique de Monaco, 98000 Monaco, Monaco.

PubMed

Insights

Targeting integrin-αvβ3 may improve medulloblastoma radiotherapy by inducing ferroptosis. This pediatric brain tumor treatment strategy leverages the link between integrin-αvβ3 expression and resistance to oxidative stress.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Pathways

Background:

  • Medulloblastoma, a pediatric brain tumor, has poor outcomes upon relapse.
  • Integrin-αvβ3 expression was previously linked to radioresistance in medulloblastoma cells.
  • Ferroptosis, a regulated cell death, is induced by reactive oxygen species (ROS) and inhibited by antioxidants.

Purpose of the Study:

  • To investigate the relationship between integrin-αvβ3 expression, ferroptosis inhibition, and medulloblastoma sensitivity to radiotherapy.
  • To elucidate the role of integrin-αvβ3 signaling in oxidative stress resilience and cell death mechanisms.

Main Methods:

  • Utilized β3-subunit knockout (β3_KO) medulloblastoma cell models.
  • Assessed lipid hydroxyperoxide accumulation post-radiotherapy to indicate ferroptosis.
  • Correlated β3-subunit expression with radiotherapy sensitivity and levels of anti-ferroptotic proteins.

Main Results:

  • Irradiated β3_KO medulloblastoma cells predominantly underwent ferroptosis.
  • β3-subunit expression positively correlated with radiotherapy sensitivity.
  • Integrin-αvβ3 signaling appears to enhance oxidative stress resilience through mTORC1 activation.

Conclusions:

  • Integrin-αvβ3 expression is associated with resistance to ferroptosis in medulloblastoma.
  • Targeting integrin-αvβ3 may represent a novel strategy to enhance radiotherapy efficacy.
  • Inducing ferroptotic cell death via integrin-αvβ3 inhibition could improve treatment outcomes for medulloblastoma.

Related Concept Videos